Skip to main content
Clinical Trials/CTRI/2020/04/024612
CTRI/2020/04/024612
Not yet recruiting
未知

COMPARATIVE EFFICACY OF 2 INJECTION METHODS WITH ARTICAINE FOR TREATMENT IN MANDIBULAR MOLARS WITH SYMPTOMATIC IRREVERSIBLE PULPITIS. A CONSORT RANDOMIZED DOUBLE-BLIND CLINICAL TRIAL : AN IN-VIVO STUDY.

Dr Harsh Jain0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K040- Pulpitis
Sponsor
Dr Harsh Jain
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Harsh Jain

Eligibility Criteria

Inclusion Criteria

  • 1\. Systemically healthy patients.
  • 2\. Patients 18â??65 years old.
  • 3\. Not allergic to articaine or epinephrine.
  • 4\. No facial paresthesia.
  • 5\. Not taking any analgesic drug 6 hours before treatment.
  • 6\. Not taking any medication that interferes with anesthesia, such as tricyclic antidepressants and beta\-blockers.
  • 7\. The absence of pathogenesis in areas planned for injection.
  • 8\. Not pregnant.
  • 9\. The absence of pathologic periodontal pockets during probing.
  • 10\. Patients with a mandibular molar tooth exhibiting symptomatic irreversible pulpitis.

Exclusion Criteria

  • 1\. A standard inferior alveolar nerve block injection will be performed using articaine 4% with epinephrine 1:100,000\. Ten minutes after the injection, the patients will be asked about lip numbness. Patients without profound lip numbness will be excluded from the study because the block will be considered â??missedâ?? which will also be confirmed with electric pulp sensibility test.
  • 2\. Participants with periapical lesions, abscesses or cellulites at the relevant tooth, those with a medical treatment history or those having undergone root canal treatment for the relevant tooth will also be excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials